Frontiers

Frontline–Boosting Accrual

The OSUCCC-James designed a culture-changing program to raise clinical trail participation rates By William E. Carson III, MD Associate Director for Clinical Research, The Ohio State University Comprehensive Canc ...[Read more]
Published: Oct-11-10 | 10  Comments | 0  Link to this post

Breakthrough–The Frontiers of Cancer Research

‘GROW OR GO’ SWITCH Researchers discover brain tumor mechanism Researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC-Jame ...[Read more]
Published: Oct-11-10 | 14  Comments | 0  Link to this post

Of Note

GRANTS Tim H.-M. Huang, PhD, professor of Molecular Virology, Immunology and Medical Genetics, has been awarded an $8.6 million, five-year renewal grant from the NCI for computational genome analysis for br ...[Read more]
Published: Oct-11-10 | 10  Comments | 0  Link to this post

Deep Thinking

Using next-generation gene sequencing to explore the depths of the genome By Darrell E. Ward Photography by Roman Sapecki Leukemia research reached a milestone in 1994 with the discovery of the MLL PTD ...[Read more]
Published: Oct-11-10 | 14  Comments | 0  Link to this post

One for All

When specialized technology and expertise is needed, OSUCCC-James researchers turn to the cancer center’s shared resources By Darrell E. Ward Illustrations by Richard Lillash Mutations in a gene called BLM cause Bloo ...[Read more]
Published: Oct-11-10 | 12  Comments | 0  Link to this post

Signature Work

Pictured left are (L to R): Steven Clinton, MD, PhD, prostate cancer specialist and researcher and director of the Prostate and Genitourinary Oncology Clinic; Debra Zynger, MD, urologic pathologist and Periannan Kup ...[Read more]
Published: Oct-11-10 | 9  Comments | 0  Link to this post

Bench to Bedside

OSU-09067 – Phase II Trial of Temsirolimus and Bevacizumab in Patients with Carcinoid Cancer HYPOTHESIS: Temsirolimus (CCI-779) and bevacizumab (Avastin) combined will induce stable disease in patients with carcinoid cancer. RATIONALE: Carcino ...[Read more]
Published: Oct-11-10 | 15  Comments | 0  Link to this post

Need to Know

ProjectONE Construction Kicks Off on Ohio State’s New Cancer Hospital A new era of cancer care and research at The Ohio State University began June 18th when the University broke ground for ProjectONE, a $1 billion initiative that includes ...[Read more]
Published: Oct-11-10 | 2  Comments | 0  Link to this post